Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,234,285,396
+$278,044,254 QoQ
Shares Held
17,387,435
+6.9% QoQ
Ownership
0.705%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#23
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 68%
None 32%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. MRK ranks #4 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,234,285,396 | 17,387,435 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,956,241,142 | 16,262,708 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,681,466,288 | 15,974,409 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,337,332,978 | 15,933,909 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,044,789,298 | 13,198,450 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,157,804,274 | 12,898,889 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,389,204,770 | 13,964,664 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,949,278,404 | 17,165,185 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,058,185,520 | 16,625,085 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,239,354,061 | 16,971,232 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,789,377,962 | 16,413,300 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,709,138,010 | 16,601,632 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,965,233,050 | 17,031,225 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,843,163,871 | 17,324,597 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $2,101,205,934 | 18,938,314 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,649,807,984 | 19,157,083 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,620,053,698 | 17,769,592 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,368,371,231 | 16,677,285 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,210,975,455 | 15,800,828 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $969,578,613 | 12,908,782 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,041,888,887 | 13,397,054 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,257,006,855 | 16,305,697 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,422,841,400 | 17,394,157 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,559,933,865 | 18,805,704 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,708,036,704 | 22,087,624 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,683,646,772 | 21,882,603 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||